The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...

Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.

All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra ® for men - in a proprietary topical formulation demonstrated to work where women nee ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...